Dow Tumbles Over 1%; Nio Shares Edge Lower After Q2 Results - Celularity (NASDAQ:CELU), CARISMA Therapeutics (NASDAQ:CARM)

NIO (NIO) Q2 2025 Earnings Call Transcript @themotleyfool #stocks $NIO

Dow Tumbles Over 1%; Nio Shares Edge Lower After Q2 Results - Celularity (NASDAQ:CELU), CARISMA Therapeutics (NASDAQ:CARM)

Nio rises despite earnings miss as its delivery growth beats rivals

Chinese EV company Nio posted a deeper net loss and lower revenue than Wall Street expected....

Earnings Snapshot: NIO Q2 revenue hits $2.65B, up 9% YoY; vehicle sales jump 62% from Q1

Earnings Snapshot: NIO Q2 revenue hits $2.65B, up 9% YoY; vehicle sales jump 62% from Q1

EV maker Nio posts 0.3% wider Q2 net loss of 5.1 billion yuan despite top-line growth

Chinese electric vehicle (EV) maker Nio announced on Tuesday (Sep 2) that its net loss deepened by 0.3 per cent on the year to 5.1 billion yuan (S$928.4 million) for its second quarter ended Jun 30, 2025.

Nio reveals strong Q2 growth, but Analysts warn of risks

Nio (NYSE: NIO) reported second-quarter 2025 revenue of $2.65 billion, up 9% year-over-year, as vehicle deliveries climbed 25.6% to 72,056 units on September 2.  The Chinese EV maker also issued upbeat guidance, forecasting deliveries of 87,000 to 91,000 in Q3, a gain of 40.7% to 47.1% annually, alongside revenue of $3.05 to $3.19 billion. https://twitter.com/NIOGlobal/status/1962816725990416588 Prior to the results, JPMorgan’s Nick Lai already…